We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit
FLACU

Delisted

FLACU was delisted on the 22nd of November, 2022.

Back to rankings

37 hedge funds and large institutions have $64.4M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

48% less capital invested

Capital invested by funds: $124M → $64.4M (-$59.2M)

48% less funds holding

Funds holding: 71 → 37 (-34)

89% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 38

Holders
37
Holders Change
-34
Holders Change %
-47.89%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
10
Closed
38
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$799K
2
WCMNY
Westchester Capital Management (New York)
New York
+$742K
3
BFM
Boothbay Fund Management
New York
+$140K
4
HF
HRT Financial
New York
+$125K
5
MA
MYDA Advisors
New York
+$110K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.42M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.73M
3
DCM
DG Capital Management
New York
-$4.68M
4
SSA
Schonfeld Strategic Advisors
New York
-$4.3M
5
GL
Governors Lane
New York
-$4.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$15.3M – – –
RCM
2
RA Capital Management
Massachusetts
$10.2M – – –
BI
3
BVF Inc
California
$5.11M – – –
Ensign Peak Advisors
4
Ensign Peak Advisors
Utah
$4.59M – – –
MA
5
MYDA Advisors
New York
$4.17M +$110K +10,299 +3%
GCM
6
Ghisallo Capital Management
Massachusetts
$3.31M -$21.3K -2,000 -0.6%
BCLSI
7
Bain Capital Life Sciences Investors
Massachusetts
$3.05M – – –
GCL
8
Glazer Capital LLC
New York
$2.98M -$93.6K -8,783 -3%
Millennium Management
9
Millennium Management
New York
$2.29M -$2.95M -276,333 -55%
MF
10
Magnetar Financial
Illinois
$2.04M – – –
EC
11
EcoR1 Capital
California
$2.03M – – –
CCM
12
Context Capital Management
California
$1.23M – – –
BCM
13
BlueCrest Capital Management
Jersey
$1.02M – – –
TAL
14
TIG Advisors LLC
New York
$975K -$42.8K -4,011 -4%
HF
15
HRT Financial
New York
$964K +$125K +11,749 +14%
WCMNY
16
Westchester Capital Management (New York)
New York
$951K +$742K +69,631 +291%
IC
17
Ikarian Capital
Texas
$766K +$799K +75,000 New
BCM
18
Bluefin Capital Management
New York
$698K -$17.2K -1,611 -2%
LCM
19
Laurion Capital Management
New York
$511K – – –
CIM
20
Cowen Investment Management
New York
$406K -$107K -10,000 -20%
LIM
21
Longfellow Investment Management
Massachusetts
$305K – – –
BFM
22
Boothbay Fund Management
New York
$280K +$140K +13,141 +91%
BCM
23
Barometer Capital Management
Ontario, Canada
$254K – – –
MTCM
24
Mint Tower Capital Management
Netherlands
$199K -$57.6K -5,400 -22%
WC
25
Wealthspring Capital
New York
$167K -$10.7K -1,000 -6%
1
2 3

FLACU Hedge Fund Activity: Q1 2021 in Review

37 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q1 2021, worth a combined $64.4M — down 48% from $124M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of FLACU and 4 opened new positions — a net loss of 34 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $799K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $7.42M sold.

  • 37 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q1 2021, down from 71 in Q4 2020.
  • Funds reported $64.4M of Frazier Lifesciences Acquisition Corporation Unit stock for Q1 2021, down 48% quarter-over-quarter.
  • 4 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q1 2021 and 38 closed out, a net change of -34 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q1 2021 was Ikarian Capital, an estimated $799K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q1 2021 was Alyeska Investment Group, an estimated $7.42M sold.

Based on aggregated 13F filings for Q1 2021.